Optimizing Patient Outcomes Lung Cancer Treatment Solutions for 2025 Pharma Executives
Lung cancer remains a formidable global health challenge, but the landscape of its treatment is undergoing a rapid and profound transformation. In 2025, the lung cancer therapeutics market is a hotbed of innovation, driven by breakthroughs in targeted therapies, immunotherapies, and the increasingly pivotal role of artificial intelligence. This a